Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

444.42 -1.35 (-0.30%)
Streaming Delayed Price Updated: 10:32 AM EDT, Jun 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
74 75 Next >
News headline image
3 Monster Stocks in the Making to Buy Right Now ↗
They're small now, but these stocks could grow much larger. 
Via The Motley Fool
News headline image
The 3 Best Neuroscience Biotech Stocks to Buy Now ↗
Given the high bar to developing good neuroscience drugs, firms that do so will likely succeed. Here are three top biotech stocks to buy now. 
Via InvestorPlace
News headline image
Looking for growth without the hefty price tag? Consider NASDAQ:VRTX. ↗
VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) is not too expensive for the growth it is showing. 
Via Chartmill
News headline image
3 Gene Editing Stocks That Could Grow Your Wealth ↗
Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks. 
Via InvestorPlace
News headline image
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? ↗
CRISPR Therapeutics could start reporting product revenue soon. 
Via The Motley Fool
News headline image
Bull Market and Beyond: 2 Stocks Just Waiting to Soar ↗
These innovative drugmakers are hard to ignore. 
Via The Motley Fool
News headline image
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals ↗
 
Via Benzinga
News headline image
Check Out What Whales Are Doing With VRTX ↗
 
Via Benzinga
News headline image
Why the quality investor may take a look at NASDAQ:VRTX. ↗
Examining the Quality Attributes of NASDAQ:VRTX. 
Via Chartmill
News headline image
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split ↗
Revenue is climbing at these two drug companies -- and the trend should continue. 
Via The Motley Fool
News headline image
Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever ↗
These companies have what it takes to stand the test of time in a portfolio. 
Via The Motley Fool
News headline image
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 ↗
Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge. 
Via InvestorPlace
News headline image
Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health. 
Via Talk Markets
News headline image
3 No-Brainer Stocks to Buy in July ↗
Investors shouldn't have to think too hard about these great stocks. 
Via The Motley Fool
News headline image
$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today ↗
 
Via Benzinga
News headline image
3 Pharma Stocks Already Ushering in the Next Biotech Boom ↗
So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider. 
Via InvestorPlace
News headline image
Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon). ↗
Vertex shares have advanced by triple digits over the past few years. 
Via The Motley Fool
News headline image
The 3 Best Biotech Stocks to Buy in July 2024 ↗
For investors looking for promising biotech investments should explore the best biotech stocks to watch in July 2024. 
Via InvestorPlace
News headline image
1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever ↗
It's not too late to get in on the act. 
Via The Motley Fool
News headline image
Did Vertex Pharmaceuticals Just Invent the Next Ozempic? ↗
Vertex Pharmaceuticals likely has a breakthrough medicine on its hands. 
Via The Motley Fool
News headline image
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead ↗
Eli Lilly is a good stock to buy, but these should be even better. 
Via The Motley Fool
News headline image
3 Top-Rated Gene Editing Stocks Actually Making Money ↗
Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond. 
Via InvestorPlace
News headline image
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout. 
Via MarketBeat
Topics ETFs
News headline image
Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
3 Under-the-Radar Biotech Stocks With Blockbuster Potential ↗
Are you looking to boost your portfolio with the best under-the-radar biotech stocks? Here are the top three. 
Via InvestorPlace
News headline image
Vertex to Announce Second Quarter 2024 Financial Results on August 1
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
3 Breakout Biotech Stocks on Track to Double by 2032 ↗
The tech sector has been at the forefront of the market rally in 2024. Consider these breakout biotech stocks as a great way to diversify. 
Via InvestorPlace
News headline image
Bull Market Buys: 2 Growth Stocks to Own for the Long Run ↗
The latest bull market has plenty of intriguing buying opportunities. 
Via The Motley Fool
News headline image
2 Superior Growth Stocks to Buy if You Have $1,000 Right Now ↗
Growth stocks with wide moats and strong financials can compound investor returns with time. 
Via The Motley Fool
News headline image
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 ↗
These healthcare stocks have clear paths to growth over the next few years. 
Via The Motley Fool
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
74 75 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.